Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo.
Saved in:
| Title: | Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo. |
|---|---|
| Authors: | Xu, Xuezhen1 (AUTHOR), Kwon, Ok-Kyoung2,3 (AUTHOR), Shin, In-Sik4 (AUTHOR), Mali, Jyotirling R.1 (AUTHOR), Harmalkar, Dipesh S.1 (AUTHOR), Lim, Yourim3 (AUTHOR), Lee, Gilhye3 (AUTHOR), Lu, Qili1 (AUTHOR), Oh, Sei-Ryang3 (AUTHOR), Ahn, Kyung-Seop3 (AUTHOR), Jeong, Hye-Gwang2 (AUTHOR) hgjeong@cnu.ac.kr, Lee, Kyeong1 (AUTHOR) kaylee@dongguk.edu |
| Source: | Scientific Reports. 1/29/2019, Vol. 9 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-018-36925-9 |